Haematology Flashcards
What is Essential Thrombocytopenia (ET)?
A chronic myeloproliferative disorder characterised by sustained dysregulation of megakaryocytic formation resulting in increased levels of circulating platelets.
Usually identified on routine blood test.
What are the features of ET?
Asymptomatic
Erythromyalgia (burning sensation in peripheries)
Arterial/venous thrombosis
Headaches
Increased risk of miscarriage/MI/stroke
Dizziness/paraesthesia
Hepatomegaly
Haemorrhage
Lived reticularis
50-70yo
Female
Priapism
Syncope and seizures
What are the laboratory features for ET?
FBC with differential (platelets >450x10^9)
Bone marrow biopsy (large megakaryocytes)
Peripheral smear
Genetic testing (JAK2 mutation)
CRP/ESR
Serum ferritin
LDH (normal)
Hb normal
What are the risk factors for ET?
Genetic mutations
- JAK2 (most common, increased risk of thrombosis)
- CALR
- MPL
Normally they kidneys and liver makes thrombopoietin which acts on haematopoietic stem cells. This activates JAK2 which causes proliferation to megakaryocytes and therefore platelets.
When mutated this pathway is always on.
What are the differentials for ET?
Infection
Tissue injury
Acute/chronic inflammation (IBD/RA)
Cancer
Haemorrhage
Other myeloproliferative condition
Iron deficiency
Redistribution of platelets (post-splenectomy/hyposplenism)
What is the management for ET?
Low risk
- Modify comorbidities
- Aspirin (anti platelet to prevent clot development)
High risk
- Chemotherapy (hydroxycarbamine/interferon alpha)
- Plasmapheresis
- Give allopurinol after treatment due to increased cell turnover and high levels of uric acid
What are the side effects of hydroxycarbamine?
Mouth & skin ulcers (give B12/folate)
Poor wound healing (switch to interferon if due operation)
What is the MOA of aspirin?
Irreversibly inhibits cyclo-oxygenase (COX1 inhibitor) and blocks the production of thromboxane.
What is the follow up for ET?
Asymptomatic: blood counts every 3 months
After chemo once stable: haemogram and platelets every 3-4 months
What is the prognosis for ET?
Normal life expectancy
Development to AML and myelofibrosis is rare
What are the complications of ET?
AML
Myelofibrosis
Arterial and venous thrombosis
Haemorrhage (acquired VWD)- seen in cases of really bad thrombocytosis
Spontaneous abortion/IUD/IUGR
What is polycythaemia vera (PCV)?
Philadelphia chromosome negative myeloproliferative neoplasm. Clonal haematopoietic disorder characterised by erythrocytosis, and often thrombocytosis, leucocytosis and splenomegaly.
Increased risk of bleeding and thrombosis.
What are the clinical features of PCV?
Aquatic pruritus (due to increased basophils/mast cells releasing histamine)
Plethoric complexion
Thromboembolism (DVT/Stroke/MI/Budd-Chiari Syndrome: liver veins blocked by clots)
Hyperviscosity symptoms (dizziness/headache/visual disturbances/myalgia/fatigue)
Splenomegaly (excess RBCs build up in spleen)
Burning peripheries
Gout/kidney stones (increased uric acid levels from increased cell turnover)
Bruising
Hyperhydrosis
What are the investigations for PCV?
FBC with differential
- Hct >0.52 (males) >0.48 (females) (Haematocrit is the volume of blood of total blood volume made up of erythrocytes, normally 0.45)
- Raised Hb, raised WCC, raised platelets
Serum EPO
Serum ferritin
Renal and liver function
Genetic testing (JAK2 mutation)
(You get microcytic erythrocytes in PCV, however the Hb is not reduced)
What are the differentials for PCV?
Relative
- dehydration
- alcohol excess
- diuretics
Primary
- PCV
Secondary
- Central hypoxia
- Renal hypoxia
- Hepatocellular carcinoma
- Renal cell carcinoma
- Uterine tumours
- Phaechromocytoma
- Wilm’s tumour
(Ectopic EPO)
What are the risk factors for PCV?
JAK2 mutation
Age >40 (median age 60)
How do you manage PCV?
Venesection (if >5x per year, other treatment is required)
Aspirin 75mg daily
Anticoagulation if thrombus already present (rivaroxaban)
Chemotherapy (interferon/hydroxycarbimide)
Antihistamine for pruritus (cetirizine: non-sedating, chlorphenamine: sedating)
What are the complications of PCV?
AML
Myelofibrosis (spent phase)
Haemorrhage
Thrombosis
Treatment related leukaemia
Pruritus
How do you follow up a patient with PCV?
Continuous blood monitoring
Chemo: every 1-2 weeks until stable, then every 3-6 months
Monitor complications
What is the prognosis of PCV?
Normal life expectancy.
Risk of development to AML/myelofibrosis/severe thrombosis
Deaths are usually from cardiovascular complications.
What is the spent phase of PCV?
Normally the kidneys produce EPO which bind to the JAK2 gene on haemaotpoeitic stem cells.
Mutation means that JAK2 is always activated. Cells divide in absence of EPO.
Mutated cels proliferate and become the predominant haematopoietic stem cells in marrow.
Eventually these cells die out and form scar tissue so marrow can no longer produce blood cells: anaemia, thrombocytopenia, leukopenia= MYELOFIBROSIS (requires blood transfusion)
What is myelofibrosis?
Myeloproliferative disorder
Abnormal production of WBC, RBCs and platelets and associated marrow fibrosis with extramedullary haematopoiesis.
Hyperplasia of abnormal megakaryocytes. Release platelet derived fibroblast growth factor which stimulates fibroblasts (connective tissue cells)
What are the risk factors for myelofibrosis?
Radiation exposure
Industrial solvent exposure
Age >65
What are the classifications of myelofibrosis?
Primary
- Mutation in the JAKSTAT pathway
- Results in rapid cell division which fills up the bone marrow
- Mostly megakaryocytes
Secondary
- PCV
- ET